Lista de obras - Roberta Zappasodi - Dominio Público Uruguay

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab

artículo científico publicado en 2014

Alphavirus-based vaccines in melanoma: rationale and potential improvements in immunotherapeutic combinations

artículo científico

Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine

artículo científico publicado en 2020

CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors

artículo científico publicado en 2020

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

artículo científico publicado en 2015

Combination of alphavirus replicon particle-based vaccination with immunomodulatory antibodies: therapeutic activity in the B16 melanoma mouse model and immune correlates.

artículo científico publicado en 2014

Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

scientific article published on 04 July 2019

HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma.

artículo científico publicado en 2015

Immunotherapy advances in uro-genital malignancies

artículo científico publicado en 2016

Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death.

artículo científico publicado en 2010

Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment ⬇️

artículo científico publicado en 2024

Lymphoma Immunotherapy: Current Status

artículo científico publicado en 2015

MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT

artículo científico publicado en 2022

Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat

artículo científico publicado en 2017

Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas.

artículo científico publicado en 2014

Rational design of anti-GITR-based combination immunotherapy

scientific article published on 29 April 2019

Sialidase NEU4 is involved in glioblastoma stem cell survival.

artículo científico publicado en 2014

The New Era of Cancer Immunotherapy: Manipulating T-Cell Activity to Overcome Malignancy.

artículo científico

The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells

artículo científico publicado en 2008

Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

artículo científico publicado en 2019

Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.

artículo científico publicado en 2010

Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study.

artículo científico publicado en 2008

Lista de obras de Roberta Zappasodi

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab

Alphavirus-based vaccines in melanoma: rationale and potential improvements in immunotherapeutic combinations

Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine

CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

Combination of alphavirus replicon particle-based vaccination with immunomodulatory antibodies: therapeutic activity in the B16 melanoma mouse model and immune correlates.

Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma.

Immunotherapy advances in uro-genital malignancies

Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death.

Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment ⬇️

Lymphoma Immunotherapy: Current Status

MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT

Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat

Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas.

Rational design of anti-GITR-based combination immunotherapy

Sialidase NEU4 is involved in glioblastoma stem cell survival.

The New Era of Cancer Immunotherapy: Manipulating T-Cell Activity to Overcome Malignancy.

The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells

Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.

Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study.